Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
Clover Biopharmaceuticals files for Hong Kong IPO
Clover Biopharmaceuticals filed for an initial public offering in Hong Kong. The company did not disclose the offering size; Goldman Sachs and CICC will sponsor the listing.
2020
CEPI and Clover expand vaccine-development partnership
CEPI announced an expanded partnership with Clover to advance development and manufacture of Clover’s S-Trimer COVID-19 vaccine candidate. CEPI will make an additional $66 million upfront investment to support clinical development and manufacturing scale-up.
2020
CEPI and Clover Australia announce COVID-19 vaccine development partnership
CEPI announced a partnership with Clover Biopharmaceuticals AUS Pty Ltd (Clover Australia), including an initial US$3.5 million investment to support preparation and initiation of an Australian phase 1 trial of Clover’s COVID-19 S-Trimer vaccine candidate.